Solid Biosciences (SLDB) Research & Development (2017 - 2024)
Solid Biosciences (SLDB) has disclosed Research & Development for 8 consecutive years, with $30.8 million as the latest value for Q4 2024.
- Quarterly Research & Development rose 99.12% to $30.8 million in Q4 2024 from the year-ago period, while the trailing twelve-month figure was $96.4 million through Dec 2024, up 25.95% year-over-year, with the annual reading at $140.3 million for FY2025, 45.52% up from the prior year.
- Research & Development hit $30.8 million in Q4 2024 for Solid Biosciences, up from $27.3 million in the prior quarter.
- In the past five years, Research & Development ranged from a high of $30.8 million in Q4 2024 to a low of $13.4 million in Q2 2020.
- Historically, Research & Development has averaged $18.8 million across 5 years, with a median of $17.8 million in 2023.
- Biggest five-year swings in Research & Development: crashed 41.91% in 2020 and later skyrocketed 99.12% in 2024.
- Year by year, Research & Development stood at $15.7 million in 2020, then fell by 7.17% to $14.6 million in 2021, then skyrocketed by 45.87% to $21.3 million in 2022, then dropped by 27.42% to $15.5 million in 2023, then surged by 99.12% to $30.8 million in 2024.
- Business Quant data shows Research & Development for SLDB at $30.8 million in Q4 2024, $27.3 million in Q3 2024, and $19.5 million in Q2 2024.